TRIUMPH-1 (80 Weeks) The pivotal TRIUMPH-1 obesity trial (2,339 adults, no diabetes), presented at ADA 2026, extended the treatment window to 80 weeks and produced the largest pivotal weight-loss readout to date: Among the 12 mg group, 45.3% lost at least 30% of their body weight and 65.3% ended the trial with a BMI below 30
The predicted difference between the two groups was estimated using the chi-squared test
Injectable carnitine, either alone or as part of a Lipo-C injection, delivers all the medication to the bloodstream for maximum absorption
Diabetic macular oedema
However, using them to manage breast pain is not advisable and can pose severe health risks, including tissue damage or even cancer
Active ingredient : The main chemical in a medication responsible for its effects Glucagon-like peptide-1 (GLP-1) : A hormone that regulates hunger and blood sugar